Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1967 1
1970 1
1971 2
1972 1
1974 2
1975 3
1976 6
1977 2
1978 5
1979 5
1980 4
1981 7
1982 8
1983 10
1984 8
1985 16
1986 18
1987 19
1988 13
1989 26
1990 38
1991 31
1992 27
1993 33
1994 33
1995 42
1996 65
1997 48
1998 39
1999 48
2000 32
2001 56
2002 55
2003 42
2004 35
2005 47
2006 37
2007 48
2008 39
2009 43
2010 44
2011 52
2012 57
2013 79
2014 63
2015 66
2016 45
2017 50
2018 64
2019 73
2020 78
2021 78
2022 59
2023 56
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

1,689 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Alopecia, androgenetic, 1"
Page 1
Androgenetic alopecia.
Piraccini BM, Alessandrini A. Piraccini BM, et al. G Ital Dermatol Venereol. 2014 Feb;149(1):15-24. G Ital Dermatol Venereol. 2014. PMID: 24566563 Review.
Androgenetic alopecia (AGA) is the most common form of alopecia, affecting up to 80% of men and 50% of women in the course of their life. ...Today, scalp dermoscopy is used routinely in patients with androgenetic alopecia, as it facilitat
Androgenetic alopecia (AGA) is the most common form of alopecia, affecting up to 80% of men and 50% of women in the
Pediatric Alopecia Areata.
Afford R, Leung AKC, Lam JM. Afford R, et al. Curr Pediatr Rev. 2021;17(1):45-54. doi: 10.2174/1573396316666200430084825. Curr Pediatr Rev. 2021. PMID: 32351186 Review.
BACKGROUND: Alopecia areata (AA) is a non-scarring hair loss disorder of autoimmune etiology. ...Nonspecific nail changes may be present. Other clinical variants include alopecia totalis, alopecia universalis, ophiasis, sisaipho, and Canitis subita. ...
BACKGROUND: Alopecia areata (AA) is a non-scarring hair loss disorder of autoimmune etiology. ...Nonspecific nail changes may be pres …
Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis.
Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, Shapiro J. Strazzulla LC, et al. J Am Acad Dermatol. 2018 Jan;78(1):1-12. doi: 10.1016/j.jaad.2017.04.1141. J Am Acad Dermatol. 2018. PMID: 29241771 Review.
Alopecia areata (AA) is a common, inflammatory, nonscarring type of hair loss. ...Part one of this two-part continuing medical education series describes the epidemiology, clinical evaluation, prognosis, and recent advancements in the understanding of the pathogenes
Alopecia areata (AA) is a common, inflammatory, nonscarring type of hair loss. ...Part one of this two-part continuing medical educat
Evaluation and diagnosis of the hair loss patient: part I. History and clinical examination.
Mubki T, Rudnicka L, Olszewska M, Shapiro J. Mubki T, et al. J Am Acad Dermatol. 2014 Sep;71(3):415.e1-415.e15. doi: 10.1016/j.jaad.2014.04.070. J Am Acad Dermatol. 2014. PMID: 25128118 Review.
Hair loss (alopecia) is a common problem and is often a major source of distress for patients. The differential diagnosis of alopecia includes both scarring and nonscarring alopecias. In addition, many hair shaft disorders can produce hair shaft fragility, resulting …
Hair loss (alopecia) is a common problem and is often a major source of distress for patients. The differential diagnosis of alope
Evaluation of the Safety and Effectiveness of Nutritional Supplements for Treating Hair Loss: A Systematic Review.
Drake L, Reyes-Hadsall S, Martinez J, Heinrich C, Huang K, Mostaghimi A. Drake L, et al. JAMA Dermatol. 2023 Jan 1;159(1):79-86. doi: 10.1001/jamadermatol.2022.4867. JAMA Dermatol. 2023. PMID: 36449274
Quality was assessed with Oxford Centre for Evidence Based Medicine criteria. Outcomes of interest were disease course, both objectively and subjectively measured. Data were evaluated from January 3 to 11, 2022. ...Kimchi and cheonggukjang, vitamin D3, and Forti5 had low-q …
Quality was assessed with Oxford Centre for Evidence Based Medicine criteria. Outcomes of interest were disease course, both objectiv …
Microneedling in androgenetic alopecia; comparing two different depths of microneedles.
Faghihi G, Nabavinejad S, Mokhtari F, Fatemi Naeini F, Iraji F. Faghihi G, et al. J Cosmet Dermatol. 2021 Apr;20(4):1241-1247. doi: 10.1111/jocd.13714. Epub 2020 Sep 29. J Cosmet Dermatol. 2021. PMID: 32897622
BACKGROUND: Microneedling has shown to have positive therapeutic effects in treatment of androgenetic alopecia (AGA); however, the best microneedling protocol is still controversial. ...RESULTS: Compared with the baseline, a significant increase in hair count and ha …
BACKGROUND: Microneedling has shown to have positive therapeutic effects in treatment of androgenetic alopecia (AGA); however, …
Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis.
Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E, Silverberg JI. Lee HH, et al. J Am Acad Dermatol. 2020 Mar;82(3):675-682. doi: 10.1016/j.jaad.2019.08.032. Epub 2019 Aug 19. J Am Acad Dermatol. 2020. PMID: 31437543
BACKGROUND: Alopecia areata (AA) is a common autoimmune alopecia with heterogeneous severity and distribution. Previous studies found conflicting results about AA epidemiology. OBJECTIVE: To determine the prevalence, incidence, and predictors of AA, alopec
BACKGROUND: Alopecia areata (AA) is a common autoimmune alopecia with heterogeneous severity and distribution. Previous studie …
Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines.
Fukuyama M, Ito T, Ohyama M. Fukuyama M, et al. J Dermatol. 2022 Jan;49(1):19-36. doi: 10.1111/1346-8138.16207. Epub 2021 Oct 28. J Dermatol. 2022. PMID: 34709679 Review.
Alopecia areata (AA) is a relatively common nonscarring hairloss disease characterized by an autoimmune response to anagen hair follicles (HFs). ...Considering the relatively high incidence of spontaneous regression in mild AA and its intractability in severe subsets, the
Alopecia areata (AA) is a relatively common nonscarring hairloss disease characterized by an autoimmune response to anagen hair folli
Alopecia areata - Current understanding and management.
Lintzeri DA, Constantinou A, Hillmann K, Ghoreschi K, Vogt A, Blume-Peytavi U. Lintzeri DA, et al. J Dtsch Dermatol Ges. 2022 Jan;20(1):59-90. doi: 10.1111/ddg.14689. J Dtsch Dermatol Ges. 2022. PMID: 35040577
Alopecia areata (AA) is a chronic, immune-mediated disease characterized by acute or chronic non-scarring hair loss, with a heterogeneity in clinical manifestations ranging from patchy hair loss to complete scalp and body hair loss. ...Since the latter is so challenging an
Alopecia areata (AA) is a chronic, immune-mediated disease characterized by acute or chronic non-scarring hair loss, with a heterogen
Update on trichoscopy: Integration of the terminology by systematic approach and a proposal of a diagnostic flowchart.
Kinoshita-Ise M, Sachdeva M. Kinoshita-Ise M, et al. J Dermatol. 2022 Jan;49(1):4-18. doi: 10.1111/1346-8138.16233. Epub 2021 Nov 22. J Dermatol. 2022. PMID: 34806223 Review.
The findings are categorized into five subgroups: hair shaft, follicular, perifollicular, scalp findings, and hair distribution pattern abnormalities. The calculation of sensitivities and positive predictive values of such redefined findings was conducted by reviewing the …
The findings are categorized into five subgroups: hair shaft, follicular, perifollicular, scalp findings, and hair distribution pattern abno …
1,689 results